(CIDRAP News) A bioterrorist attack that caused mass casualties would very likely lead to shortages of medical resources, so preparedness planning must include a careful look at how to ration those resources fairly, an emergency medicine specialist told a conference audience in Minneapolis this week.
(CIDRAP News) The National Institute of Allergy and Infectious Diseases (NIAID) has released a 68-page report on its plan for expanding research on "Category A" bioterrorism agents: anthrax, smallpox, plague, tularemia, viral hemorrhagic fevers, and botulism.
(CIDRAP News) The Food and Drug Administration (FDA) this week endorsed a widespread cosmetic procedure by approving the use of botulinum toxin type A to temporarily smooth frown lines between the eyebrows.
(CIDRAP News) The United States' food supply makes an attractive target for terrorists, and people in the food industry need to talk more frankly about the risks, bioterrorism expert Michael T. Osterholm, PhD, MPH, said in a Minneapolis speech yesterday.
Editor's note: This story was updated Jan 30, 2003, with additional information from the Department of Health and Human Services.
(CIDRAP News) – President Bush yesterday proposed an initiative, called Project Bioshield, to speed the development and production of vaccines and treatments for smallpox, anthrax, botulism, and other diseases that could be spread by terrorists.
(CIDRAP News) Six months after President Bush proposed the idea, the US House this week overwhelmingly passed "Project Bioshield," a plan to promote the development of drugs and vaccines needed to defend the nation against attacks with biological and other unconventional weapons.
(CIDRAP News) Federal health officials yesterday released a 37-page report that they say demonstrates "tremendous progress" in developing countermeasures for bioterrorism through federally funded research since early 2002.